Nonmalignant Neoplasm: Clinical Trials

4 trials for Nonmalignant Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Terminated 1

Follow Nonmalignant Neoplasm: new trials by email Literature Review of Nonmalignant Neoplasm trials Research Report on Nonmalignant Neoplasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers
cytology specimen collection procedure, fluorescent antibody technique, assessment of therapy complications - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Not applicableTerminatedCity of Hope Medical Center92008-11-012015-06-08
MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
dutasteride - Nonmalignant Neoplasm, Prostate Cancer
Not applicableCompletedUniversity of California, San Francisco102005-06-012014-01-17
Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
anti-thymocyte globulin, busulfan, cyclosporine - Leukemia, Lymphoma
Not applicableCompletedAsan Medical Center302004-04-012013-03-26
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
lycopene, laboratory biomarker analysis, biopsy - Nonmalignant Neoplasm, Prostate Cancer
Not applicableCompletedUniversity of Illinois at Chicago1202013-09-20

Narrower conditions

Neoplasms (4)  ·  Anemia, Aplastic (2)  ·  Blast Crisis (2)  ·  Burkitt Lymphoma (2)  ·  Congenital Abnormalities (2)  ·  Hodgkin Disease (2)  ·  Immunoblastic Lymphadenopathy (2)  ·  Leukemia (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Myeloid, Accelerated Phase (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Leukemia, Myeloid, Chronic-Phase (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Lymphoma (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)

Broader conditions

Neoplasms by Site (3)  ·  Anemia (2)  ·  Blood Protein Disorders (2)  ·  Bone Marrow Diseases (2)  ·  Bone Marrow Failure Disorders (2)  ·  Carcinogenesis (2)  ·  Cardiovascular Diseases (2)  ·  Cell Transformation, Neoplastic (2)  ·  Chronic Disease (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  DNA Virus Infections (2)  ·  Disease Attributes (2)  ·  Epstein-Barr Virus Infections (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)

Interventions

Antilymphocyte Serum (1)  ·  Biopsy (1)  ·  Busulfan (1)  ·  Cyclosporine (1)  ·  Dutasteride (1)  ·  Fluorescent Antibody Technique (1)  ·  Lycopene (1)  ·  Methotrexate (1)  ·  Methylprednisolone (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  fludarabine phosphate (1)

Sponsors

Asan Medical Center (1)  ·  City of Hope Medical Center (1)  ·  University of California, San Francisco (1)  ·  University of Illinois at Chicago (1)

Countries

United States (2)  ·  South Korea (1)

Top investigators

Aprille Seidel, PhD (1)  ·  Kyoo H. Lee, MD (1)  ·  Mack Roach, MD (1)  ·  Richard B. van Breemen, PhD (1)

Results publications

PMID 21430075, PMID 21715313

NIH funding

P30CA033572 (1)